glp-1 and medicare What is the Bridge? Bridge is a new CMS program starting on July 1 that may help eligible Medicare patients access certain GLP-1 obesity medications. If you are on Medicare Medicare to cover GLP-1 weight

Takeaway on Safe Use NativePath Native Creatine is supported by extensive research and is safe for most adults when used responsibly

Only vitamin E supplementation significantly increased the overall rate of improvement in histological abnormalities that characterize MASH on liver biopsies (i.e., hepatocellular ballooning, steatosis, and lobular inflammation) (98)

Patients with less subcutaneous fat may benefit from shorter needles to minimize the risk of intramuscular injections, which can be painful and affect insulin absorption

Very exciting to see what is next

Given the relationship between diabetes and chronic kidney disease, it should come as no surprise that GLP1 receptor agonists can positively impact the clinical trajectory of those with kidney disease